IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,289,612 | -21.6% | 133,916 | -14.4% | 0.00% | 0.0% |
| Q2 2023 | $1,645,024 | 0.0% | 156,371 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,645,024 | -19.7% | 156,371 | -5.4% | 0.00% | 0.0% |
| Q4 2022 | $2,048,735 | -99.8% | 165,354 | +29.0% | 0.00% | 0.0% |
| Q3 2022 | $1,327,624,000 | -1.4% | 128,149 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $1,346,554,000 | -55.4% | 116,787 | -51.4% | 0.00% | 0.0% |
| Q1 2022 | $3,020,105,000 | +7.9% | 240,072 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,799,239,000 | -82.6% | 240,072 | -80.5% | 0.00% | -85.7% |
| Q3 2021 | $16,052,177,000 | -34.5% | 1,229,110 | -35.5% | 0.01% | -30.0% |
| Q2 2021 | $24,520,889,000 | +18.2% | 1,905,275 | +2.7% | 0.01% | +11.1% |
| Q1 2021 | $20,751,041,000 | -25.5% | 1,856,086 | -24.1% | 0.01% | -30.8% |
| Q4 2020 | $27,840,156,000 | -10.4% | 2,444,263 | -29.2% | 0.01% | -23.5% |
| Q3 2020 | $31,070,908,000 | -53.3% | 3,454,242 | -46.4% | 0.02% | -58.5% |
| Q2 2020 | $66,469,748,000 | -16.1% | 6,440,867 | -18.0% | 0.04% | -28.1% |
| Q1 2020 | $79,265,939,000 | -31.9% | 7,855,891 | -10.2% | 0.06% | -19.7% |
| Q4 2019 | $116,385,740,000 | +27.2% | 8,744,233 | -18.0% | 0.07% | +14.5% |
| Q3 2019 | $91,495,201,000 | -18.0% | 10,657,564 | +4.5% | 0.06% | -22.5% |
| Q2 2019 | $111,574,490,000 | +15.8% | 10,198,765 | +43.2% | 0.08% | +12.7% |
| Q1 2019 | $96,388,169,000 | +26.2% | 7,124,033 | -3.4% | 0.07% | +7.6% |
| Q4 2018 | $76,380,748,000 | -33.1% | 7,372,659 | +19.1% | 0.07% | -22.4% |
| Q3 2018 | $114,241,538,000 | -7.5% | 6,188,599 | -4.2% | 0.08% | -10.5% |
| Q2 2018 | $123,536,805,000 | +38.6% | 6,461,130 | +11.8% | 0.10% | +35.7% |
| Q1 2018 | $89,135,436,000 | -6.5% | 5,776,762 | -9.1% | 0.07% | -13.6% |
| Q4 2017 | $95,311,726,000 | -5.7% | 6,358,354 | -0.8% | 0.08% | -12.0% |
| Q3 2017 | $101,041,687,000 | +48.6% | 6,407,209 | +78.0% | 0.09% | +39.4% |
| Q2 2017 | $67,973,098,000 | +196.7% | 3,600,270 | +168.1% | 0.07% | +187.0% |
| Q1 2017 | $22,907,536,000 | +2940533.6% | 1,342,763 | +2537.3% | 0.02% | +2200.0% |
| Q4 2016 | $779,000 | -35.2% | 50,915 | -32.8% | 0.00% | 0.0% |
| Q3 2016 | $1,203,000 | +23.6% | 75,785 | +1.9% | 0.00% | 0.0% |
| Q2 2016 | $973,000 | +22.5% | 74,385 | +2.5% | 0.00% | 0.0% |
| Q1 2016 | $794,000 | -29.4% | 72,542 | -25.2% | 0.00% | 0.0% |
| Q4 2015 | $1,124,000 | +15.0% | 96,942 | +3.4% | 0.00% | 0.0% |
| Q3 2015 | $977,000 | +29.2% | 93,734 | +49.5% | 0.00% | 0.0% |
| Q2 2015 | $756,000 | -6.2% | 62,697 | +24.4% | 0.00% | 0.0% |
| Q1 2015 | $806,000 | +21.0% | 50,397 | +15.9% | 0.00% | 0.0% |
| Q4 2014 | $666,000 | +17.7% | 43,497 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $566,000 | -13.7% | 43,697 | +2.1% | 0.00% | 0.0% |
| Q2 2014 | $656,000 | +31.5% | 42,797 | +5.7% | 0.00% | 0.0% |
| Q1 2014 | $499,000 | +17.1% | 40,497 | +10.4% | 0.00% | – |
| Q4 2013 | $426,000 | +43.4% | 36,697 | +46.2% | 0.00% | – |
| Q3 2013 | $297,000 | +18.8% | 25,097 | 0.0% | 0.00% | – |
| Q2 2013 | $250,000 | – | 25,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |